Lila AI Designs New CAR-T Cancer Therapy

JinghanOng posted that three Lila scientists designed a new CAR-T cancer therapy in months. The post states the therapy outperformed a leading one used in patients today during preclinical testing. CAR-T normally requires years and high cost, the post adds. Scobleizer quoted the post with the remark "But AI is bad, right?" A linked Lila.ai page reports the platform first found ultra-stable mRNA then the CAR-T therapy outperformed the leading option in non-human primates.